Profile for Five Prime Therapeutics, Inc. (FPRX)
« Back to company indexFPRX Chatter Timeline
Stock Ticker for FPRX
Most Active Tweeters for FPRX
| User | Tweets |
|---|---|
| @TickerReport | 7 |
| @SPNewsAnalysis | 5 |
| @emq_news | 5 |
| @chaffeybreeze | 3 |
| @intercooleronli | 3 |
Recent Tweets for FPRX
 |
@JasonHolman5 Imagine the v. low ORR doesn't bode well for $FPRX, FPA008. https://t.co/YY3mx0lNAh July 24th 2017, 6:07pm |
 |
@WarrenofWallSt Traditional fundamentals don't apply to Biotechs like #FivePrimeTherapeutics $FPRX https://t.co/ngo1kcFMVt https://t.co/gCsvgJmWPw July 23rd 2017, 10:07am |
 |
@dailymailtimes Brokerages Set Five Prime Therapeutics, Inc. $FPRX Target Price at $65.20 https://t.co/ib90UHia9x July 22nd 2017, 7:07pm |
 |
@IRAMarketReport Teachers Retirement System of The State of Kentucky Has $866,000 Position in Five Prime Therapeutics, Inc. $FPRX https://t.co/LWVwc97ag2 July 22nd 2017, 10:07am |
 |
@chaffeybreeze Teachers Retirement System of The State of Kentucky Has $866,000 Position in Five Prime Therapeutics, Inc. $FPRX https://t.co/oE8kUUKh2P July 22nd 2017, 10:07am |
 |
@emq_news Five Prime Therapeutics, Inc. $FPRX Shares Sold by TIAA CREF Investment Management LLC https://t.co/Mf1OkTpZKL July 22nd 2017, 9:07am |
|
@chaffeybreeze TIAA CREF Investment Management LLC Reduces Position in Five Prime Therapeutics, Inc. $FPRX https://t.co/MQwf5bAA7P July 22nd 2017, 9:07am |
|
@IRAMarketReport TIAA CREF Investment Management LLC Reduces Position in Five Prime Therapeutics, Inc. $FPRX https://t.co/yZLh6bwUGw July 22nd 2017, 8:07am |
 |
@wulamkam $fprx consolidation pattern /shows sign of accumulation https://t.co/5xsTJBxI0Q July 22nd 2017, 7:07am |
 |
@portefeuillefun Sold 800 $FPRX at $30.21, now 800 #vssporte shares. July 21st 2017, 11:07am |
|
@emq_news Five Prime Therapeutics, Inc. $FPRX Stake Raised by Goldman Sachs Group Inc. https://t.co/LThZgM4Nek July 21st 2017, 10:07am |
 |
@TickerReport Five Prime Therapeutics, Inc. $FPRX Stake Raised by Goldman Sachs Group Inc. https://t.co/VMAuI6tT37 July 21st 2017, 10:07am |
|
@emq_news Brokerages Anticipate Five Prime Therapeutics, Inc. $FPRX Will Post Quarterly Sales of $10.15 Million https://t.co/SRKuNMJFH2 July 20th 2017, 12:07am |
|
@TickerReport Brokerages Anticipate Five Prime Therapeutics, Inc. $FPRX Will Post Quarterly Sales of $10.15 Million https://t.co/KAWQ7L5cvm July 20th 2017, 12:07am |
 |
@dakotafinancial Five Prime Therapeutics, Inc. $FPRX Expected to Announce Quarterly Sales of $10.15 Million https://t.co/StkPXSBj5p July 20th 2017, 12:07am |
|
@TickerReport Brokerages Anticipate Five Prime Therapeutics, Inc. $FPRX Will Post Quarterly Sales of $10.15 Million https://t.co/UvH2IiE4ma July 19th 2017, 11:07pm |
 |
@1stOncology First Dosing in Phase 1 Safety Trial Evaluating #FPA144 in #GastricCancer $FPRX https://t.co/W6pxhb9lx3 July 19th 2017, 12:07pm |
 |
@tgtxdough WF $FPRX Expanded Development Of FPA144 To Asia Should Increase Opportunity In Gastric Cancer https://t.co/wpyrAv8sQk July 18th 2017, 7:07am |
|
@emq_news Five Prime Therapeutics, Inc. $FPRX Given Consensus Recommendation of “Buy” by Brokerages https://t.co/sDHa8uGKGu July 17th 2017, 9:07pm |
 |
@storminvestor Five Prime Therapeutics, Inc. $FPRX Given Consensus Recommendation of “Buy” by Brokerages https://t.co/c1HTVoPI86 July 17th 2017, 9:07pm |
 |
@SPNewsAnalysis Five Prime Therapeutics, Inc. $FPRX Given Consensus Recommendation of “Buy” by Brokerages https://t.co/noQLlRo0u9 July 17th 2017, 9:07pm |
|
@TickerReport Five Prime Therapeutics, Inc. $FPRX Given Consensus Recommendation of “Buy” by Brokerages https://t.co/38wO4ljQva July 17th 2017, 9:07pm |
|
@TickerReport Five Prime Therapeutics, Inc. $FPRX Given Consensus Recommendation of “Buy” by Brokerages https://t.co/I3nNk6NyiC July 17th 2017, 8:07pm |
 |
@intercooleronli Five Prime Therapeutics, Inc. $FPRX Given Consensus Recommendation of “Buy” by Brokerages https://t.co/teUvZzSFpF July 17th 2017, 8:07pm |
 |
@YoungChris27040 RT @odibro: $FPRX Initiates Patient Dosing in Phase 1 Clinical Safety Trial Evaluating FPA144 in Gastric Cancer in Japan https://t.co/CYvG… July 17th 2017, 7:07pm |
 |
@Briefingcom $FPRX: Five Prime Therapeutics initiated dosing in its Phase 1 clinical trial of FPA144, an anti-FGF receptor 2b... https://t.co/uoh9S5afI6 July 17th 2017, 6:07pm |
|
@emq_news Five Prime Therapeutics, Inc. $FPRX Expected to Post Earnings of -$1.18 Per Share https://t.co/Gf1JfOWuOq July 17th 2017, 5:07pm |
|
@TickerReport Five Prime Therapeutics, Inc. $FPRX Expected to Post Earnings of -$1.18 Per Share https://t.co/bb9vAFjjzh July 17th 2017, 5:07pm |
|
@SPNewsAnalysis Five Prime Therapeutics, Inc. $FPRX Expected to Post Earnings of -$1.18 Per Share https://t.co/bzjDY15N0M July 17th 2017, 5:07pm |
|
@TickerReport Five Prime Therapeutics, Inc. $FPRX Expected to Post Earnings of -$1.18 Per Share https://t.co/D7HnMUrNw8 July 17th 2017, 5:07pm |
 |
@MyAlliesTrading $FPRX Five Prime Therapeutics Initiates Patient Dosing in Phase 1 Clinical Safety Trial Evaluating FPA144 in G... https://t.co/d9Vao2tQ3P July 17th 2017, 4:07pm |
 |
@stockboardinc $FPRX Five Prime Therapeutics Initiates Patient Dosing in Phase 1 Clinical Safety Trial Evaluating FPA144 ... - https://t.co/Uzx5z8jEz7 July 17th 2017, 4:07pm |
 |
@stocknewsdotcom $FPRX Initiated dosing in its Phase 1 clinical trial of FPA144, an anti-FGF receptor 2b antibody, in patients with… https://t.co/MrrbZeJQW4 July 17th 2017, 4:07pm |
 |
@odibro $FPRX Initiates Patient Dosing in Phase 1 Clinical Safety Trial Evaluating FPA144 in Gastric Cancer in Japan https://t.co/CYvGsIlEfl July 17th 2017, 4:07pm |
 |
@GNWLive Five Prime Therapeutics Initiates Patient Dosing in Phase 1 Clinical Safety Trial Evaluating FPA144 in $FPRX https://t.co/sKItirOAlc July 17th 2017, 4:07pm |
|
@portefeuillefun Sold 400 $FPRX at $30.40, now 1600 #vssporte shares. July 17th 2017, 11:07am |
 |
@VeeDub78 I want to go long $FPRX but it's a COMPLETE gamble. I know nothing about the company, I just like buying dips. July 17th 2017, 7:07am |
|
@SPNewsAnalysis Five Prime Therapeutics $FPRX Given News Impact Score of 0.35 https://t.co/qWv8Y80rtx July 16th 2017, 10:07am |
|
@storminvestor Five Prime Therapeutics $FPRX Given News Impact Score of 0.35 https://t.co/XV7WXH8HNZ July 16th 2017, 10:07am |
|
@intercooleronli Five Prime Therapeutics, Inc. $FPRX Expected to Announce Quarterly Sales of $10.15 Million https://t.co/h68kSBpm0c July 16th 2017, 8:07am |
 |
@dailypoliticaln Five Prime Therapeutics, Inc. $FPRX Expected to Announce Quarterly Sales of $10.15 Million https://t.co/4AiihAgihy July 16th 2017, 8:07am |
 |
@1MinuteStock Btw, Estimated #Earnings Per Share for $FPRX is $-1.02 it's -3.48% of the current price https://t.co/DX86jWrkOj July 16th 2017, 3:07am |
|
@1MinuteStock Not sure what to do with $FPRX? Explore our #fundamental pros and cons. https://t.co/A9LtiK4Woc July 16th 2017, 3:07am |
|
@SPNewsAnalysis Analysts Anticipate Five Prime Therapeutics, Inc. $FPRX Will Announce Earnings of -$1.18 Per Share https://t.co/akBkf1V6UP July 15th 2017, 4:07pm |
|
@dakotafinancial Five Prime Therapeutics, Inc. $FPRX Expected to Post Quarterly Sales of $10.15 Million https://t.co/CrHdkWqWhN July 15th 2017, 3:07pm |
|
@dakotafinancial Five Prime Therapeutics $FPRX Earning Positive News Coverage, Report Shows https://t.co/GwnSWZN5oM July 14th 2017, 8:07pm |
 |
@SleekMoneycom Five Prime Therapeutics, Inc. $FPRX Expected to Announce Earnings of -$1.18 Per Share https://t.co/LYnuYOZDxP July 14th 2017, 4:07pm |
|
@intercooleronli Five Prime Therapeutics, Inc. $FPRX Expected to Announce Earnings of -$1.18 Per Share https://t.co/6GgFOvIMTb July 14th 2017, 2:07pm |
 |
@MarginHunt Our valuation shows 26% upside for Five Prime Therapeutics, Inc. $FPRX while @ 47% of 52week high… https://t.co/zzCeZ0cjax July 13th 2017, 8:07pm |
|
@portefeuillefun Sold 500 $FPRX at $30.00, now 2000 #vssporte shares. July 13th 2017, 3:07pm |
Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.